NO20082938L - Formuleringer av quinolinoner - Google Patents
Formuleringer av quinolinonerInfo
- Publication number
- NO20082938L NO20082938L NO20082938A NO20082938A NO20082938L NO 20082938 L NO20082938 L NO 20082938L NO 20082938 A NO20082938 A NO 20082938A NO 20082938 A NO20082938 A NO 20082938A NO 20082938 L NO20082938 L NO 20082938L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- quinolinones
- formulations
- tautomer
- salt
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 229930185107 quinolinone Natural products 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 229960000913 crospovidone Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74057705P | 2005-11-29 | 2005-11-29 | |
| US74131705P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/045711 WO2007064719A2 (en) | 2005-11-29 | 2006-11-29 | Formulations of quinolinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082938L true NO20082938L (no) | 2008-06-30 |
Family
ID=38024178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082938A NO20082938L (no) | 2005-11-29 | 2008-06-30 | Formuleringer av quinolinoner |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20080293738A1 (ru) |
| EP (2) | EP2772257A1 (ru) |
| JP (1) | JP2009517481A (ru) |
| KR (1) | KR20080074143A (ru) |
| CN (1) | CN102670530A (ru) |
| AR (1) | AR062545A1 (ru) |
| AU (1) | AU2006320591B2 (ru) |
| BR (1) | BRPI0619370A2 (ru) |
| CA (1) | CA2627544C (ru) |
| CL (1) | CL2010000387A1 (ru) |
| EC (1) | ECSP088467A (ru) |
| ES (1) | ES2467162T3 (ru) |
| IL (1) | IL190865A0 (ru) |
| MA (1) | MA29969B1 (ru) |
| MY (1) | MY148529A (ru) |
| NO (1) | NO20082938L (ru) |
| NZ (1) | NZ567550A (ru) |
| PE (1) | PE20070760A1 (ru) |
| PL (1) | PL1957074T3 (ru) |
| PT (1) | PT1957074E (ru) |
| RU (1) | RU2433826C2 (ru) |
| TW (1) | TW200730176A (ru) |
| WO (1) | WO2007064719A2 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR070924A1 (es) | 2008-03-19 | 2010-05-12 | Novartis Ag | Formas cristalinas y dos formas solvatadas de sales del acido lactico de 4- amino -5- fluoro-3-(5-(4-metilpiperazin-1-il ) -1h- bencimidazol-2-il) quinolin -2-(1h) - ona |
| EP2285803A4 (en) | 2008-05-23 | 2011-10-05 | Amira Pharmaceuticals Inc | Inhibitor of 5-Lipoxygenase Activating Protein |
| US20110092515A1 (en) * | 2008-07-03 | 2011-04-21 | Zhihui Qiu | Melt granulation process |
| UY33472A (es) * | 2010-06-30 | 2012-01-31 | Novartis Ag | ?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?. |
| WO2013063003A1 (en) | 2011-10-28 | 2013-05-02 | Novartis Ag | Method of treating gastrointestinal stromal tumors |
| CA2861377A1 (en) | 2012-01-31 | 2013-08-08 | Novartis Ag | Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer |
| EP2872142A1 (en) | 2012-07-11 | 2015-05-20 | Novartis AG | Method of treating gastrointestinal stromal tumors |
| WO2014058785A1 (en) | 2012-10-10 | 2014-04-17 | Novartis Ag | Combination therapy |
| TWI535784B (zh) | 2014-08-26 | 2016-06-01 | 財團法人工業技術研究院 | 剪切增稠配方、及包含其之複合材料 |
| CN113329734A (zh) | 2018-12-06 | 2021-08-31 | 葛兰素史克知识产权开发有限公司 | 新颖的药物制剂 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663606A (en) * | 1966-06-21 | 1972-05-16 | Mitsui Toatsu Chemicals | Organic imino-compounds |
| DE2363459A1 (de) | 1973-12-20 | 1975-06-26 | Basf Ag | Neue fluoreszierende chinolinverbindungen |
| US4119105A (en) | 1977-01-31 | 1978-10-10 | Olin Corporation | Air flow limiting filter |
| JPH0699497B2 (ja) | 1987-04-16 | 1994-12-07 | 富士写真フイルム株式会社 | 光重合性組成物 |
| GB9108547D0 (en) | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| JP3161780B2 (ja) | 1991-09-30 | 2001-04-25 | 東レ・ダウコーニング・シリコーン株式会社 | α，ω−ジヒドロキシフルオロアルキルメチルポリシロキサンの製造方法 |
| JP3142378B2 (ja) | 1992-06-22 | 2001-03-07 | ティーディーケイ株式会社 | 有機ｅｌ素子 |
| US5763441A (en) | 1992-11-13 | 1998-06-09 | Sugen, Inc. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| JPH0743896A (ja) | 1993-07-28 | 1995-02-14 | Toyobo Co Ltd | 光重合性組成物 |
| JPH0829973A (ja) | 1994-07-11 | 1996-02-02 | Toyobo Co Ltd | 光重合性組成物 |
| JP3441246B2 (ja) | 1995-06-07 | 2003-08-25 | 富士写真フイルム株式会社 | 光重合性組成物 |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| US6010711A (en) * | 1996-01-26 | 2000-01-04 | University Of Rochester | Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors |
| WO1997034876A1 (en) | 1996-03-15 | 1997-09-25 | Zeneca Limited | Cinnoline derivatives and use as medicine |
| DE19610723A1 (de) | 1996-03-19 | 1997-09-25 | Bayer Ag | Elektrolumineszierende Anordnungen unter Verwendung von Blendsystemen |
| JP2000514048A (ja) | 1996-06-20 | 2000-10-24 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 薬理学的活性調製物を提供するための化合物および方法ならびにそれらの使用 |
| KR100567649B1 (ko) | 1996-09-25 | 2006-04-05 | 아스트라제네카 유케이 리미티드 | 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체 |
| WO2001052904A2 (en) | 2000-01-19 | 2001-07-26 | Gill Parkash S | Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| US20030027818A1 (en) * | 2001-04-03 | 2003-02-06 | Redmond H. Paul | Treatment of cancers |
| GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
| EP1005470B1 (en) | 1997-08-22 | 2007-08-01 | AstraZeneca AB | Oxindolylquinazoline derivatives as angiogenesis inhibitors |
| AU3850299A (en) | 1998-05-20 | 1999-12-06 | Kyowa Hakko Kogyo Co. Ltd. | Vegf activity inhibitors |
| US6138605A (en) | 1998-08-05 | 2000-10-31 | Seascape Systems Limited | Access and evacuation apparatus with articulated arm |
| DE19841985A1 (de) | 1998-09-03 | 2000-03-09 | Schering Ag | Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate |
| IL126953A0 (en) | 1998-11-08 | 1999-09-22 | Yeda Res & Dev | Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives |
| PE20010306A1 (es) | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
| YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
| EP1248642A4 (en) | 2000-01-18 | 2005-05-18 | Ludwig Inst Cancer Res | PEPTIDOMIMETIC INHIBITOR OF VEGF AND VEGF-C AND -D |
| GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
| PL202918B1 (pl) * | 2000-03-07 | 2009-08-31 | Rush Presbyterian St Luke | Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie |
| ES2334641T3 (es) | 2000-09-01 | 2010-03-15 | Novartis Vaccines And Diagnostics, Inc. | Derivados aza heterociclicos y su uso terapeutico. |
| SG174632A1 (en) | 2000-09-11 | 2011-10-28 | Novartis Vaccines & Diagnostic | Quinolinone derivatives |
| US20030028018A1 (en) | 2000-09-11 | 2003-02-06 | Chiron Coporation | Quinolinone derivatives |
| US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| EP1539754A4 (en) | 2002-08-23 | 2009-02-25 | Novartis Vaccines & Diagnostic | BENZIMIDAZOLE QUINOLINONES AND USES THEREOF |
| US7825132B2 (en) * | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
| KR20050075005A (ko) | 2002-11-13 | 2005-07-19 | 카이론 코포레이션 | 암을 치료하는 방법 및 관련 방법 |
| WO2005046589A2 (en) | 2003-11-07 | 2005-05-26 | Chiron Corporation | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| BRPI0507891A (pt) * | 2004-02-20 | 2007-07-24 | Chiron Corp | modulação dos processos inflamatório e metastático |
| US20060261307A1 (en) * | 2005-05-18 | 2006-11-23 | Black D J | Water Activated Organic Scavenger |
| RU2425041C2 (ru) * | 2005-05-23 | 2011-07-27 | Новартис Аг | Кристаллические и другие формы солей, образованных из молочной кислоты и 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1н-бензимидазол-2-ил]-1н-хинолин-2-она |
-
2006
- 2006-11-29 EP EP14150490.2A patent/EP2772257A1/en not_active Withdrawn
- 2006-11-29 PL PL06838590T patent/PL1957074T3/pl unknown
- 2006-11-29 AR ARP060105279A patent/AR062545A1/es unknown
- 2006-11-29 JP JP2008543426A patent/JP2009517481A/ja active Pending
- 2006-11-29 MY MYPI20081687A patent/MY148529A/en unknown
- 2006-11-29 RU RU2008126384/15A patent/RU2433826C2/ru not_active IP Right Cessation
- 2006-11-29 US US12/094,806 patent/US20080293738A1/en not_active Abandoned
- 2006-11-29 EP EP06838590.5A patent/EP1957074B1/en active Active
- 2006-11-29 AU AU2006320591A patent/AU2006320591B2/en not_active Ceased
- 2006-11-29 CN CN2012100464971A patent/CN102670530A/zh active Pending
- 2006-11-29 CA CA2627544A patent/CA2627544C/en not_active Expired - Fee Related
- 2006-11-29 KR KR1020087012826A patent/KR20080074143A/ko not_active Application Discontinuation
- 2006-11-29 PE PE2006001517A patent/PE20070760A1/es not_active Application Discontinuation
- 2006-11-29 PT PT68385905T patent/PT1957074E/pt unknown
- 2006-11-29 WO PCT/US2006/045711 patent/WO2007064719A2/en active Application Filing
- 2006-11-29 ES ES06838590.5T patent/ES2467162T3/es active Active
- 2006-11-29 BR BRPI0619370-6A patent/BRPI0619370A2/pt not_active IP Right Cessation
- 2006-11-29 TW TW095144180A patent/TW200730176A/zh unknown
- 2006-11-29 NZ NZ567550A patent/NZ567550A/en not_active IP Right Cessation
-
2008
- 2008-04-14 IL IL190865A patent/IL190865A0/en unknown
- 2008-05-20 MA MA30953A patent/MA29969B1/fr unknown
- 2008-05-23 EC EC2008008467A patent/ECSP088467A/es unknown
- 2008-06-30 NO NO20082938A patent/NO20082938L/no not_active Application Discontinuation
-
2010
- 2010-04-19 CL CL2010000387A patent/CL2010000387A1/es unknown
-
2012
- 2012-07-05 US US13/542,216 patent/US20120276200A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1957074A2 (en) | 2008-08-20 |
| ECSP088467A (es) | 2008-06-30 |
| PL1957074T3 (pl) | 2014-08-29 |
| AU2006320591A1 (en) | 2007-06-07 |
| NZ567550A (en) | 2011-08-26 |
| WO2007064719A3 (en) | 2007-08-16 |
| CL2010000387A1 (es) | 2010-08-06 |
| EP2772257A1 (en) | 2014-09-03 |
| TW200730176A (en) | 2007-08-16 |
| IL190865A0 (en) | 2008-11-03 |
| ES2467162T3 (es) | 2014-06-12 |
| US20080293738A1 (en) | 2008-11-27 |
| WO2007064719A2 (en) | 2007-06-07 |
| RU2433826C2 (ru) | 2011-11-20 |
| CN102670530A (zh) | 2012-09-19 |
| CA2627544A1 (en) | 2007-06-07 |
| KR20080074143A (ko) | 2008-08-12 |
| BRPI0619370A2 (pt) | 2011-09-27 |
| MY148529A (en) | 2013-04-30 |
| PT1957074E (pt) | 2014-06-25 |
| CA2627544C (en) | 2015-07-07 |
| AR062545A1 (es) | 2008-11-19 |
| PE20070760A1 (es) | 2007-10-04 |
| MA29969B1 (fr) | 2008-11-03 |
| JP2009517481A (ja) | 2009-04-30 |
| US20120276200A1 (en) | 2012-11-01 |
| AU2006320591B2 (en) | 2010-06-03 |
| EP1957074B1 (en) | 2014-03-19 |
| RU2008126384A (ru) | 2010-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082938L (no) | Formuleringer av quinolinoner | |
| NO20092033L (no) | Nye forbindelser | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| NO20066055L (no) | Pyridinderivater | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| SE0400284D0 (sv) | Novel compounds | |
| WO2006096444A3 (en) | Chemical compounds | |
| NO20073720L (no) | Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20070564L (no) | Kinoliner uten tiazolinonsubstituenter. | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| WO2003082205A3 (en) | Compounds and methods | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
| NO20054787L (no) | Indenderivater som farmasotiske midler | |
| NO20082265L (no) | Dispergerbare tabletter som innbefatter deferasirox | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20075734L (no) | Tiofenforbindelser og trombopoietin reseptoractivatorer | |
| MX2009006334A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |